AstraZeneca wins speedy approvals for cancer drugs in Japan

LONDON (Reuters) - AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets.

Roche 'highly encouraged' by Tecentriq results in breast cancer

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer.

Britain's health service has started planning for Brexit no deal

LONDON (Reuters) - Britain's public health service has started "significant planning" to ensure medicines are still supplied to patients if the government fails to negotiate a Brexit deal with the European Union, it head said on Sunday.